Asset Details
Do you wish to reserve the book?
Estimating unobserved SARS-CoV-2 infections in the United States
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Estimating unobserved SARS-CoV-2 infections in the United States
Do you wish to request the book?
Estimating unobserved SARS-CoV-2 infections in the United States
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Estimating unobserved SARS-CoV-2 infections in the United States
2020
Overview
By March 2020, COVID-19 led to thousands of deaths and disrupted economic activity worldwide. As a result of narrow case definitions and limited capacity for testing, the number of unobserved severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections during its initial invasion of the United States remains unknown. We developed an approach for estimating the number of unobserved infections based on data that are commonly available shortly after the emergence of a new infectious disease. The logic of our approach is, in essence, that there are bounds on the amount of exponential growth of new infections that can occur during the first few weeks after imported cases start appearing. Applying that logic to data on imported cases and local deaths in the United States through 12 March, we estimated that 108,689 (95% posterior predictive interval [95%PPI]: 1,023 to 14,182,310) infections occurred in the United States by this date. By comparing the model’s predictions of symptomatic infections with local cases reported over time, we obtained daily estimates of the proportion of symptomatic infections detected by surveillance. This revealed that detection of symptomatic infections decreased throughout February as exponential growth of infections outpaced increases in testing. Between 24 February and 12 March, we estimated an increase in detection of symptomatic infections, which was strongly correlated (median: 0.98; 95% PPI: 0.66 to 0.98) with increases in testing. These results suggest that testing was a major limiting factor in assessing the extent of SARS-CoV-2 transmission during its initial invasion of the United States.
Publisher
National Academy of Sciences
Subject
Betacoronavirus - isolation & purification
/ Clinical Laboratory Techniques
/ Communicable Diseases, Emerging - diagnosis
/ Communicable Diseases, Emerging - epidemiology
/ Communicable Diseases, Emerging - transmission
/ Community-Acquired Infections
/ Coronavirus Infections - diagnosis
/ Coronavirus Infections - epidemiology
/ Coronavirus Infections - transmission
/ COVID-19
/ Humans
/ Pneumonia, Viral - diagnosis
/ Pneumonia, Viral - epidemiology
/ Pneumonia, Viral - transmission
/ Severe acute respiratory syndrome coronavirus 2
